Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils

Journal of Surgical Research

Volumn 80, Issue 2, 1998, Pages 149-155

  Todoroki, Hidekazu ^a   Higure, Aiichiro ^a   Okamoto, Kohji ^a   Okazaki, Keisuke ^a   Nagafuchi, Yukihisa ^a   Takeda, Shigeaki ^a   Katoh, Hidenori ^a   Itoh, Hideaki ^a   Ohsato, Keiichi ^a   Nakamura, Shin ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Neutrophil; Platelet activating factor; Tissue factor

Indexed keywords

3,5 DIMETHYL 2 (3 PYRIDYL) 4 THIAZOLIDINONE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOPLASTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CHOLANGITIS; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; GENE EXPRESSION; HISTOPATHOLOGY; LIVER; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEPSIS;

EID: 0032418517     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5348     Document Type: Article

References (33)

1. Levi M., ten Cate H., van der Poll T., van Deventer J. H. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA. 270:1993;975.
2. Furie F., Furie B. C. The molecular basis of blood coagulation. Cell. 53:1988;505.
3. Drake T. A., Morrissey J. H., Edgington T. S. Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am. J. Pathol. 134:1989;1087.
4. Scarpati E. M., Sadler J. E. Regulation of endothelial cell coagulant properties: Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J. Biol. Chem. 264:1989;20705.
5. Gregory S. A., Morrissey J. H., Edgington T. S. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol. Cell. Biol. 9:1989;2752.
6. Hanahan D. J. Platelet activating factor. A biologically active phosphoglyceride. Annu. Rev. Biochem. 55:1986;483.
7. Vargaftig B. B., Chigard M., Benveniste J., Lefort J., Wal F. Background and present status of research on platelet activating factor. Ann. N.Y. Acad. Sci. 370:1981;119.
8. Chang S. W., Feddersen C. O., Henson P. M., Voelkel N. F. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79:1987;1498.
9. Doebber T. W., Wu M. S., Robbins J. C., Choy B. M., Chang M. N., Shen T. Y. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem. Biophys. Res. Commun. 127:1985;799.
10. Terashita Z., Imura Y., Nishikawa K., Sumida S. Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur. J. Pharmacol. 109:1985;257.
11. Halonen M., Palmer J. D., Lohman I. C., McManus L. M., Pinckard R. N. Respiratory and circulatory alteration induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am. Rev. Respir. Dis. 122:1980;915.
12. Terashita Z., Imura Y., Nishikawa K., Sumida S. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio) ethyl phosphate, a specidic PAF antagonist, in endotoxin and anaphylactic shock. Adv. Prostaglandin Thromboxane Leukotrienes Res. 15:1985;715.
13. Ontell S. J., Makowka L., Ove P., Starzl T. E. Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI63-441. Gastroenterology. 95:1988;1617.
14. Imura Y., Terashita Z., Nishikawa K. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988. Life Sci. 39:1986;111.
15. Higure A., Okamoto K., Hirata K., Todoroki H., Nagafuchi Y., Takeda S. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb. Haemostasis. 75:1996;791.
16. Osterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: Requirement of platelets and granulocytes. J. Leukocyte Biol. 51:1992;462.
17. Kucey D. S., Kubicki E. I., Rotstein O. D. Platelet-activating factor primes endotoxin-stimulated macrophage procoagulant activity. J. Surg. Res. 50:1991;436.
18. Schmid E., Muller T. H., Budzinski R. M., Binder K., Pfizenmaier K. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J. Interferon Cytokine Res. 15:1995;819.
19. Ou M. C., Kambayashi J., Kawasaki T., Uemura Y., Shinozaki K., Shiba E. Potential etiologic role of PAF in two major septic complications, disseminated intravascular coagulation and multiple organ failure. Thromb. Res. 73:1994;227.
20. Kawamura M., Terashita Z., Imura Y., Shino A., Nishikawa K. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation. Thromb. Res. 70:1993;281.
21. Imanishi N., Murakami M., Uchida M., Koike H., Natsume Y., Morooka S. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethil-2-(3-pyridyl)thiazolidin-4-one hydrochloride. Arzneim-Forsch./Drug Res. 44:1994;317.
22. Morooka S., Koike H., Imanishi N., Natsume Y. SM-12502: A platelet activating factor antagonist. Cardiovasc. Drug. Rev. 13:1995;105.
23. Nakamura S., Goto A., Takemoto S., Mizuguchi J., Funatsu A. Monoclonal antibodies to human tissue factor. Thromb. Haemostasis. 65:1991;1216.
24. Imamura T., Imai K., Takeya M., Kambara T., Nakamura S. Role of macrophage tissue factor in the development of the delayed hypersensitivity reaction in monkey skin. Cell. Immunol. 152:1993;614.
25. Fukuda C., Iijima K., Nakamura K. Measuring tissue factor (factor III) activity in plasma. Clin. Chem. 35:1989;1897.
26. Murakami F., Iijima K., Fukuda C., Ikawa S. An improved assay for plasma tissue factor activity. Jap. J. Clin. Pathol. 43:1995;137.
27. Kucey D. S., Cheung P. Y. C., Rotstein O. D. Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism. Infect. Immun. 60:1992;944.
28. Maier R. V., Hahnel G. B., Fletcher J. R. Platelet-activating factor augments tumor necrosis factor and procoagulant activity. J. Surg. Res. 52:1992;258.
29. Murakami K., Okajima K., Uchiba M., Johno M., Okabe H., Takatsuki K. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats. Thromb. Haemostasis. 75:1996;965.
30. Lorant D. E., Patel K. D., McIntyre T. M., McEver R. P., Prescott S. M., Zimmerman G. A. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtracrine system for adhesion and activation of neutrophils. J. Cell Biol. 115:1991;223.
31. Lorant D. E., Topham M. K., Whatley R. E., McEver R. P., McIntyre T. M., Prescott S. M. Inflammatory roles of P-selectin. J. Clin. Invest. 92:1993;559.
32. Fan S., Edgington T. S. Coupling of adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J. Clin. Invest. 87:1991;50.
33. Tanaka T., Tsujinaka T., Kambayashi J., Higashiyama M., Yokota M., Sakon M. The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model. Thromb. Res. 60:1990;321.